Publication | Open Access
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)
251
Citations
32
References
2017
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1